Altered sirtuin expression is associated with node-positive breast cancer

British Journal of Cancer

Volumn 95, Issue 8, 2006, Pages 1056-1061

  Ashraf, N ^a   Zino, S ^a   MacIntyre, A ^a   Kingsmore, D ^b   Payne, A P ^a   George, W D ^a   Shiels, P G ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b WESTERN INFIRMARY   (United Kingdom)

Author keywords

Breast cancer; Gene expression; Sirtuins

Indexed keywords

PROTEIN P16; PROTEIN P21; SIRTUIN;

ADULT; ARTICLE; BREAST BIOPSY; BREAST CANCER; CANCER GRADING; CANCER GROWTH; CELL AGING; CONTROLLED STUDY; FEMALE; GENE; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPH NODE METASTASIS; PRIORITY JOURNAL; PROGNOSIS; REAL TIME POLYMERASE CHAIN REACTION; SIRT1 GENE; SIRT2 GENE; SIRT3 GENE; SIRT7 GENE; TUMOR BIOPSY;

ANALYSIS OF VARIANCE; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CELL AGING; CELL LINE; CELL LINE, TUMOR; CYCLIN-DEPENDENT KINASE INHIBITOR P16; CYCLIN-DEPENDENT KINASE INHIBITOR P21; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LYMPHATIC METASTASIS; MITOCHONDRIAL PROTEINS; PROGNOSIS; RNA, NEOPLASM; SIRTUIN 3; SIRTUINS;

EID: 33750212896     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6603384     Document Type: Article

References (25)

1. Borresen-Dale AL (2003) TP53 and breast cancer. Hum Mutat 21: 292-300
2. Brachmann CB, Sherman JM, Devine SE, Cameron EE, Pillus L, Boeke JD (1995) The SIR2 gene family, conserved from bacteria to humans, functions in silencing, cell cycle progression, and chromosome stability. Genes Dev 9: 2888-2902
3. CancerStats (2005) (http://info.cancerresearchuk.org/cancerstats). In Cancer Research UK
4. de Nigris F, Cerutti J, Morelli C, Califano D, Chiariotti L, Viglietto G, Santelli G, Fusco A (2002) Isolation of a SIR-like gene, SIR-T8, that is overexpressed in thyroid carcinoma cell lines and tissues. Br J Cancer 86: 917-923
5. Dimri GP, Lee X, Basile G, Acosta M, Scott G, Roskelley C, Medrano EE, Linskens M, Rubelj I, Pereira-Smith OPeacocke M, Campisi J (1995) A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc Natl Acad Sci USA 92: 9363-9367
6. Dryden SC, Nahhas FA, Nowak JE, Goustin AS, Tainsky MA (2003) Role for human SIRT2 NAD-dependent deacetylase activity in control of mitotic exit in the cell cycle. Mol Cell Biol 23: 3173-3185
7. Ford E, Voit R, Liszt G, Magin C, Grummt I, Guarente L (2006) Mammalian Sir2 homolog SIRT7 is an activator of RNA polymerase I transcription. Genes Dev 20: 1075-1080
8. Frye R (2002) 'SIRT8' expressed in thyroid cancer is actually SIRT7. Br J Cancer 87: 1479
9. Frye RA (2000) Phylogenetic classification of prokaryotic and eukaryotic Sir2-like proteins. Biochem Biophys Res Commun 273: 793-798
10. Galea MH, Blamey RW, Elston CE, Ellis IO (1992) The Nottingham Prognostic Index in primary breast cancer. Breast Cancer Res Treat 22: 207-219
11. Guarente L (1999) Diverse and dynamic functions of the Sir silencing complex. Nat Genet 23: 281-285
12. Guarente L (2000) Sir2 links chromatin silencing, metabolism, and aging. Genes Dev 14: 1021-1026
13. Hiratsuka M, Inoue T, Toda T, Kimura N, Shirayoshi Y, Kamitani H, Watanabe T, Ohama E, Tahimic CG, Kurimasa A, Oshimura M (2003) Proteomics-based identification of differentially expressed genes in human gliomas: down-regulation of SIRT2 gene. Biochem Biophys Res Commun 309: 558-566
14. Johnstone RW (2002) Histone-deacetylase inhibitors: novel drugs for the treatment of cancer. Nat Rev Drug Discov 1: 287-299
15. Luo J, Nikolaev AY, Imai S, Chen D, Su F, Shiloh A, Guarente L, Gu W (2001) Negative control of p53 by Sir2alpha promotes cell survival under stress. Cell 107: 137-148
16. Marks P, Rifkind RA, Richon VM, Breslow R, Miller T, Kelly WK (2001) Histone deacetylases and cancer: causes and therapies. Nat Rev Cancer 1: 194-202
17. Michishita E, Park JY, Burneskis JM, Barrett JC, Horikawa I (2005) Evolutionarily conserved and nonconserved cellular localizations and functions of human SIRT proteins. Mol Biol Cell 16: 4623-4635
18. Mokbel K, Ghilchik M, Williams G, Akbar N, Parris C, Newbold R (2000) The association between telomerase activity and hormone receptor status and p53 expression in breast cancer. Int J Surg Investig 1: 509-516
19. Neumeister P, Albanese C, Balent B, Greally J, Pestell RG (2002) Senescence and epigenetic dysregulation in cancer. Int J Biochem Cell Biol 34: 1475-1490
20. North BJ, Marshall BL, Borra MT, Denu JM, Verdin E (2003) The human Sir2 ortholog, SIRT2, is an NAD+-dependent tubulin deacetylase. Mol Cell 11: 437-444
21. Onyango P, Celic I, McCaffery JM, Boeke JD, Feinberg AP (2002) SIRT3, a human SIR2 homologue, is an NAD-dependent deacetylase localized to mitochondria. Proc Natl Acad Sci USA 99: 13653-13658
22. Rose G, Dato S, Altomare K, Bellizzi D, Garasto S, Greco V, Passarino G, Feraco E, Mari V, Barbi C, BonaFe M, Franceschi C, Tan Q, Boiko S, Yashin AI, De Benedictis G (2003) Variability of the SIRT3 gene, human silent information regulator Sir2 homologue, and survivorship in the elderly. Exp Gerontol 38: 1065-1070
23. Shiels PG, Davies RW (2003) Ageing and Death in Neurons. The Molecular Biology of the Neurone. 2nd edn., pp 435-464
24. Shiels PG, Jardine AG (2003) Dolly, no longer the exception: telomeres and implications for transplantation. Cloning Stem Cells 5: 157-160
25. Vaziri H, Dessain SK, Ng Eaton E, Imai SI, Frye RA, Pandita TK, Guarente L, Weinberg RA (2001) hSIR2(SIRT1) functions as an NAD-dependent p53 deacetylase. Cell 107: 149-159